Poly-β-Cyclodextrin as a Superior Host for Gemcitabine
Gemcitabine remains a vital chemotherapeutic agent, yet its rapid deamination and short systemic persistence necessitate improved delivery strategies. This study
A forum for researchers, students and applicants in the field of cyclodextrin technology
Gemcitabine remains a vital chemotherapeutic agent, yet its rapid deamination and short systemic persistence necessitate improved delivery strategies. This study
The authors hypothesized that integrating tumor-targeted topoisomerase I inhibitor delivery with optimized PARP inhibitor scheduling could enable effective combination therapy
Rutin (RTN) is a natural flavonoid with well-documented anti-angiogenic, antioxidant, anti-inflammatory, and anti-cancer properties. However, its therapeutic potential is limited
Photocatalytic degradation provides a promising sustainable solution for water purification, but its effectiveness is often limited by the low utilization
This study investigates the PEG‑β‑CD polymer, a water‑soluble polyethylene glycol–β‑cyclodextrin cross‑linked carrier, as a potential alternative to conventional oestradiol formulations
This study provides a comprehensive analysis of the structures and properties of zinc sulfide (ZnS) and dysprosium-doped ZnS nanoparticles (NPs)
A β-CDP (CycloLab) was used for the experiments. The purity of the β-CDP was >95 %. The β-CDP contained <1 % of
/The biological properties of pβCD of different molecular weights were studied. Strikingly, only the low-molecular-weight pβCD (LMW-pβCD) displayed antibacterial activity,
A high-swelling cyclodextrin polymer (His-CDP) is reported that is facilely synthesized without additional design and templates, to achieve high affinity,
Niemann–Pick disease type C (NPC) and Alzheimer’s disease (AD) are both characterised by cognitive decline and neurological impairment. In each